Inventor
SCHNEIDER DINA
US39 patents
⚠️ This page may combine multiple inventors who share the name “SCHNEIDER DINA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LENTIGEN TECH INC
35 patentsUS10844128B2Nov 24, 2020
Compositions and methods for treating cancer with anti-CD123 immunotherapy
LENTIGEN TECH INC20 citations94
US10442867B2Oct 15, 2019
Compositions and methods for treating cancer with anti-CD19/CD20 immunotherapy
LENTIGEN TECH INC17 citations94
US10428141B2Oct 1, 2019
Compositions and methods for treating cancer with anti-ROR1 immunotherapy
LENTIGEN TECH INC15 citations94
US10426797B2Oct 1, 2019
Compositions and methods for treating cancer with anti-CD33 immunotherapy
LENTIGEN TECH INC19 citations94
US11103533B2Aug 31, 2021
Compositions and methods for treating cancer with anti-CD38 immunotherapy
LENTIGEN TECH INC7 citations84
US10639329B2May 5, 2020
Method to treat cancer with engineered T-cells
LENTIGEN TECH INC12 citations84
US10550179B2Feb 4, 2020
Compositions and methods for treating cancer with anti-mesothelin immunotherapy
LENTIGEN TECH INC6 citations84
US10501539B2Dec 10, 2019
Compositions and methods for treating cancer with anti-CD19 immunotherapy
LENTIGEN TECH INC8 citations84
US10183993B2Jan 22, 2019
Compositions and methods for treating cancer with anti-mesothelin immunotherapy
LENTIGEN TECH INC11 citations84
US11242389B2Feb 8, 2022
Compositions and methods for treating cancer with anti-CD19/CD22 immunotherapy
LENTIGEN TECH INC5 citations83
US11208455B2Dec 28, 2021
Compositions and methods for treating cancer with DuoCARs
LENTIGEN TECH INC6 citations83
US10689431B2Jun 23, 2020
Compositions and methods for treating cancer with DuoCARs
LENTIGEN TECH INC8 citations83
US11052112B2Jul 6, 2021
Compositions and methods for treating cancer with anti-BCMA immunotherapy
LENTIGEN TECH INC5 citations79
US11453719B2Sep 27, 2022
Compositions and methods for treating cancer with anti-ROR1 immunotherapy
LENTIGEN TECH INC2 citations73
US11802142B2Oct 31, 2023
Compositions and methods for treating cancer with DuoCARs
LENTIGEN TECH INC1 citations72
US11453712B2Sep 27, 2022
Compositions and methods for treating cancer with DuoCARs
LENTIGEN TECH INC2 citations72
US10894819B2Jan 19, 2021
Compositions and methods for treating HIV/AIDS with immunotherapy
LENTIGEN TECH INC2 citations69
US11590169B1Feb 28, 2023
Compositions and methods for treating cancer with anti-CD123 immunotherapy
LENTIGEN TECH INC2 citations67
US12540179B2Feb 3, 2026
Compositions and methods for treating cancer with anti-ROR1 immunotherapy
LENTIGEN TECH INC0 citations62
US12391958B2Aug 19, 2025
Compositions and methods for treating cancer with anti-CD38 immunotherapy
LENTIGEN TECH INC0 citations62
US12365718B2Jul 22, 2025
Compositions and methods for treating cancer with DuoCARs
LENTIGEN TECH INC0 citations62
US12037403B2Jul 16, 2024
Compositions and methods for treating cancer with anti-CD123 immunotherapy
LENTIGEN TECH INC0 citations62
US11970528B2Apr 30, 2024
Compositions and methods for treating cancer with anti-mesothelin immunotherapy
LENTIGEN TECH INC0 citations62
US11905515B2Feb 20, 2024
Chimeric antigen receptors and methods of use
LENTIGEN TECH INC0 citations62
US11708408B2Jul 25, 2023
Compositions and methods for treating cancer with anti-CD19 immunotherapy
LENTIGEN TECH INC0 citations62
US11680103B2Jun 20, 2023
Compositions and methods for treating cancer with anti-CD19/CD20 immunotherapy
LENTIGEN TECH INC0 citations62
US11464801B2Oct 11, 2022
Compositions and methods for treating cancer with anti-CD33 immunotherapy
LENTIGEN TECH INC1 citations62
US12371490B2Jul 29, 2025
Compositions and methods for treating cancer with anti-CD19/CD22 immunotherapy
LENTIGEN TECH INC0 citations61
US12193995B2Jan 14, 2025
Method to treat cancer with engineered T-cells
LENTIGEN TECH INC0 citations61
US12122831B2Oct 22, 2024
Compositions and methods for treating cancer with anti-CD19/CD22 immunotherapy
LENTIGEN TECH INC0 citations61
US12024554B2Jul 2, 2024
Compositions and methods for treating HIV/AIDS with immunotherapy
LENTIGEN TECH INC0 citations59
US12391740B2Aug 19, 2025
Compositions and methods for treating cancer with anti-BCMA immunotherapy
LENTIGEN TECH INC0 citations58
US11969443B2Apr 30, 2024
Compositions and methods for treating cancer with self-driving chimeric antigen receptors
LENTIGEN TECH INC0 citations56
US11497770B2Nov 15, 2022
Compositions and methods for treating cancer with TSLPR-CD19 or TSLPR-CD22 immunotherapy
LENTIGEN TECH INC0 citations56
US12465641B2Nov 11, 2025
Chimeric antigen receptor therapies for treating solid tumors
LENTIGEN TECH INC0 citations42
LENTIGENTECHNOLOGY INC
3 patentsUS10543263B2Jan 28, 2020
Compositions and methods for treating cancer with anti-CD22 immunotherapy
LENTIGENTECHNOLOGY INC14 citations84
US10822412B2Nov 3, 2020
Compositions and methods for treating cancer with anti-CD19/CD22 immunotherapy
LENTIGENTECHNOLOGY INC6 citations82
US11878052B2Jan 23, 2024
Compositions and methods for treating cancer with anti-CD22 immunotherapy
LENTIGENTECHNOLOGY INC1 citations61